Search research articles
Contact Us
Filters
Showing results (191-200 of 401) with videos related to
Page
of 41
Sort By:
Breast Cancer Research and Treatment
|
June 30, 2006
Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients
Christian Schindlbeck, Udo Jeschke, Sandra Schulze, et al.
International Journal of Molecular Sciences
|
January 16, 2019
Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer
Sabine Heublein, Sabina Page, Doris Mayr, et al.
International Journal of Molecular Sciences
|
July 30, 2017
The Prostaglandin EP3 Receptor Is an Independent Negative Prognostic Factor for Cervical Cancer Patients
Helene Heidegger, Sebastian Dietlmeier, Yao Ye, et al.
Journal of Reproductive Immunology
|
July 17, 2022
The Pregnancy Zone Protein (PZP) is significantly downregulated in the placenta of preeclampsia and HELLP syndrome patients
Sanja Löb, Aurelia Vattai, Christina Kuhn, et al.
International Journal of Molecular Sciences
|
June 29, 2018
PPARγ Expression Is Diminished in Macrophages of Recurrent Miscarriage Placentas
Theresa Maria Kolben, Elisabeth Rogatsch, Aurelia Vattai, et al.
Journal of Perinatal Medicine
|
November 6, 2013
Peroxisome proliferator-activated receptor-gamma (PPARγ) is down regulated in trophoblast cells of gestational diabetes mellitus (GDM) and in trophoblast tumour cells BeWo in vitro after stimulation with PPARγ agonists
Julia Knabl, Rebecca Hüttenbrenner, Stefan Hutter, et al.
Human Reproduction Update
|
October 1, 2013
Involvement of galectin-1 in reproduction: past, present and future
Gabriela Barrientos, Nancy Freitag, Irene Tirado-González, et al.
Anticancer Research
|
June 9, 2016
Immunohistochemical Evaluation of the Role of p53 Mutation in Cervical Cancer: Ser-20 p53-Mutant Correlates with Better Prognosis
Christoph P Freier, Annika Stiasny, Christina Kuhn, et al.
International Journal of Molecular Sciences
|
March 1, 2017
Histone H3 Acetyl K9 and Histone H3 Tri Methyl K4 as Prognostic Markers for Patients with Cervical Cancer
Susanne Beyer, Junyan Zhu, Doris Mayr, et al.
International Journal of Molecular Sciences
|
March 6, 2021
Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients
Qun Wang, Aurelia Vattai, Theresa Vilsmaier, et al.
Page
of 41
Search research articles
Search
Showing results (191-200 of 401) with videos related to
Sort By:
Page
of 41
Breast Cancer Research and Treatment
|
June 30, 2006
Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients
Christian Schindlbeck, Udo Jeschke, Sandra Schulze, et al.
International Journal of Molecular Sciences
|
January 16, 2019
Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer
Sabine Heublein, Sabina Page, Doris Mayr, et al.
International Journal of Molecular Sciences
|
July 30, 2017
The Prostaglandin EP3 Receptor Is an Independent Negative Prognostic Factor for Cervical Cancer Patients
Helene Heidegger, Sebastian Dietlmeier, Yao Ye, et al.
Journal of Reproductive Immunology
|
July 17, 2022
The Pregnancy Zone Protein (PZP) is significantly downregulated in the placenta of preeclampsia and HELLP syndrome patients
Sanja Löb, Aurelia Vattai, Christina Kuhn, et al.
International Journal of Molecular Sciences
|
June 29, 2018
PPARγ Expression Is Diminished in Macrophages of Recurrent Miscarriage Placentas
Theresa Maria Kolben, Elisabeth Rogatsch, Aurelia Vattai, et al.
Journal of Perinatal Medicine
|
November 6, 2013
Peroxisome proliferator-activated receptor-gamma (PPARγ) is down regulated in trophoblast cells of gestational diabetes mellitus (GDM) and in trophoblast tumour cells BeWo in vitro after stimulation with PPARγ agonists
Julia Knabl, Rebecca Hüttenbrenner, Stefan Hutter, et al.
Human Reproduction Update
|
October 1, 2013
Involvement of galectin-1 in reproduction: past, present and future
Gabriela Barrientos, Nancy Freitag, Irene Tirado-González, et al.
Anticancer Research
|
June 9, 2016
Immunohistochemical Evaluation of the Role of p53 Mutation in Cervical Cancer: Ser-20 p53-Mutant Correlates with Better Prognosis
Christoph P Freier, Annika Stiasny, Christina Kuhn, et al.
International Journal of Molecular Sciences
|
March 1, 2017
Histone H3 Acetyl K9 and Histone H3 Tri Methyl K4 as Prognostic Markers for Patients with Cervical Cancer
Susanne Beyer, Junyan Zhu, Doris Mayr, et al.
International Journal of Molecular Sciences
|
March 6, 2021
Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients
Qun Wang, Aurelia Vattai, Theresa Vilsmaier, et al.
Page
of 41